The global Antimicrobial Susceptibility Testing (AST) Market was valued at USD 3.87 billion in 2023 and is projected to reach USD 6.04 billion by 2032, growing at a robust compound annual growth rate (CAGR) of 5.1% during the forecast period of 2024 to 2032. The market’s expansion is primarily driven by the increasing prevalence of antimicrobial resistance (AMR), the growing number...